Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 28;45(8):1047–1056. doi: 10.1097/DSS.0000000000001803

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society for Dermatologic Surgery, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 3. — Composite responders. Composite response was defined as a ≥2-level improvement or a ≥1-level improvement from baseline (Day 1) in both the CR-PCSS and PR-PCSS ratings at Day 71. ITT population: CCH, n = 189; placebo, n = 186. mITT population: CCH, n = 177; placebo, n = 184. CCH, collagenase clostridium histolyticum; CR-PCSS, Clinician Reported Photonumeric Cellulite Severity Scale; ITT, intent-to-treat; mITT, modified intent-to-treat; PR-PCSS, Patient Reported Photonumeric Cellulite Severity Scale.